Literature DB >> 26059660

Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis.

Roman Tatura1, Michael Zeschnigk2, Wiebke Hansen1, Joerg Steinmann1, Pedrina Goncalves Vidigal1, Marina Hutzler1, Eva Pastille1, Astrid M Westendorf1, Jan Buer1, Jan Kehrmann1.   

Abstract

The role of Foxp3(+) regulatory T (Treg) cells in the course of the early hyper-inflammatory and subsequent hypo-inflammatory phases of sepsis is ambiguous. Whereas Nrp1 expression has been reported to discriminate natural Treg cells from induced Treg cells, the Treg cell stability depends on the methylation status of foxp3-TSDR. To specifically evaluate the role of Foxp3(+) Treg cells in the early and late phases of sepsis, we induced sepsis by caecal ligation and puncture and subsequent Pseudomonas aeruginosa lung infection in a DEREG (DEpletion of REGulatory T cells) mouse model. We found an increase of Foxp3(+) Treg cells to all CD4(+) T cells during murine sepsis. Using a new methylation-sensitive quantitative RT-PCR method and deep amplicon sequencing, we demonstrated that natural (Nrp1(+) Foxp3(+) ) Treg cells and most induced (Nrp1(-) Foxp3(+) ) Treg cells are stable and exhibit unmethylated foxp3-TSDR, and that both Treg populations are functionally suppressive in healthy and septic mice. DEREG mice depleted of Foxp3(+) Treg cells exhibit higher disease scores, mortality rates and interleukin-6 expression levels than do non-depleted DEREG mice in early-phase sepsis, a finding indicating that Foxp3(+) Treg cells limit the hyper-inflammatory response and accelerate recovery. Treg cell depletion before secondary infection with P. aeruginosa 1 week after caecal ligation and puncture does not influence cytokine levels or the course of secondary infection. However, a moderate Treg cell recurrence, which we observed in DEREG mice during secondary infection, may interfere with these results. In summary, Treg cells contribute to a positive outcome after early-phase sepsis, but the data do not support a significant role of Treg cells in immune paralysis during late-phase sepsis.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Nrp1; Pseudomonas aeruginosa; foxp3-TSDR; methylation; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26059660      PMCID: PMC4552509          DOI: 10.1111/imm.12490

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

Review 1.  The effects of injury on the adaptive immune response.

Authors:  J A Lederer; M L Rodrick; J A Mannick
Journal:  Shock       Date:  1999-03       Impact factor: 3.454

2.  Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry.

Authors:  Manira Rayamajhi; Elizabeth F Redente; Tracy V Condon; Mercedes Gonzalez-Juarrero; David W H Riches; Laurel L Lenz
Journal:  J Vis Exp       Date:  2011-05-02       Impact factor: 1.355

Review 3.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

Review 4.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

5.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 6.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

7.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

8.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

Authors:  Katharina Lahl; Christoph Loddenkemper; Cathy Drouin; Jennifer Freyer; Jon Arnason; Gérard Eberl; Alf Hamann; Hermann Wagner; Jochen Huehn; Tim Sparwasser
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

9.  Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition.

Authors:  Milka Sarris; Kristian G Andersen; Felix Randow; Luzia Mayr; Alexander G Betz
Journal:  Immunity       Date:  2008-03-06       Impact factor: 31.745

10.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.

Authors:  Mahesh Yadav; Cedric Louvet; Dan Davini; James M Gardner; Marc Martinez-Llordella; Samantha Bailey-Bucktrout; Bryan A Anthony; Francis M Sverdrup; Richard Head; Daniel J Kuster; Peter Ruminski; David Weiss; David Von Schack; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

View more
  26 in total

1.  Loss of tissue-nonspecific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis.

Authors:  Divine C Nwafor; Sreeparna Chakraborty; Allison L Brichacek; Sujung Jun; Catheryne A Gambill; Wei Wang; Elizabeth B Engler-Chiurazzi; Duaa Dakhlallah; Anthony B Pinkerton; José Luis Millán; Stanley A Benkovic; Candice M Brown
Journal:  Brain Behav Immun       Date:  2019-11-25       Impact factor: 7.217

2.  Targeting Neuropilin-1 Suppresses the Stability of CD4+ CD25+ Regulatory T Cells via the NF-κB Signaling Pathway in Sepsis.

Authors:  Yu-Lei Gao; Chun-Xue Wang; Zi-Yi Wang; Wen-Jie Li; Yan-Cun Liu; Song-Tao Shou; Yan-Fen Chai
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

3.  Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.

Authors:  Abigail E Overacre-Delgoffe; Maria Chikina; Rebekah E Dadey; Hiroshi Yano; Erin A Brunazzi; Gulidanna Shayan; William Horne; Jessica M Moskovitz; Jay K Kolls; Cindy Sander; Yongli Shuai; Daniel P Normolle; John M Kirkwood; Robert L Ferris; Greg M Delgoffe; Tullia C Bruno; Creg J Workman; Dario A A Vignali
Journal:  Cell       Date:  2017-05-25       Impact factor: 41.582

4.  Plasmodium yoelii infection of BALB/c mice results in expansion rather than induction of CD4(+) Foxp3(+) regulatory T cells.

Authors:  Simone Abel; Kristina Ueffing; Roman Tatura; Marina Hutzler; Matthias Hose; Kai Matuschewski; Jan Kehrmann; Astrid M Westendorf; Jan Buer; Wiebke Hansen
Journal:  Immunology       Date:  2016-03-23       Impact factor: 7.397

5.  Neuropilin-1highCD4⁺CD25⁺ Regulatory T Cells Exhibit Primary Negative Immunoregulation in Sepsis.

Authors:  Yu-Lei Gao; Yan-Fen Chai; An-Long Qi; Ying Yao; Yan-Cun Liu; Ning Dong; Li-Jun Wang; Yong-Ming Yao
Journal:  Mediators Inflamm       Date:  2016-04-27       Impact factor: 4.711

6.  Removal of regulatory T cells prevents secondary chronic infection but increases the mortality of subsequent sub-acute infection in sepsis mice.

Authors:  Ruichao Huo; Lili Wang; Xiaoya Wang; Yong Zhao; Yi Wang; Xiaomin Zhao; Lingling Chang; Shan-Lu Liu; Dewen Tong; Hai Zhang; Yong Huang
Journal:  Oncotarget       Date:  2016-03-08

7.  Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells.

Authors:  Yu Pan; Haizong Fang; Fengchun Lu; Minggui Pan; Fei Chen; Ping Xiong; Yi Yao; Heguang Huang
Journal:  J Inflamm (Lond)       Date:  2017-03-20       Impact factor: 4.981

8.  Tuftsin prevents the negative immunoregulation of neuropilin-1highCD4+CD25+Regulatory T cells and improves survival rate in septic mice.

Authors:  Yu-Lei Gao; Mu-Ming Yu; Song-Tao Shou; Ying Yao; Yan-Cun Liu; Li-Jun Wang; Bin Lu; Yan-Fen Chai
Journal:  Oncotarget       Date:  2016-12-06

Review 9.  Asthma and COVID-19: a dangerous liaison?

Authors:  Carlo Lombardi; Federica Gani; Alvise Berti; Pasquale Comberiati; Diego Peroni; Marcello Cottini
Journal:  Asthma Res Pract       Date:  2021-07-15

Review 10.  HDL and persistent inflammation immunosuppression and catabolism syndrome.

Authors:  Grant Barker; Julia R Winer; Faheem W Guirgis; Srinivasa Reddy
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.